KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024
17 Julho 2024 - 5:05PM
Business Wire
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the
“Company”), a leading medical technology company focused on
development, manufacturing, and commercialization of innovative and
patient-centric large volume subcutaneous infusion solutions, today
announced that the Company will report second quarter 2024
financial results on Wednesday, August 7, 2024. KORU Medical’s
management will host a conference call and webcast at 4:30 p.m. ET
that day to discuss the financial results and provide a corporate
update.
Conference Call and Webcast Details
The conference call can be accessed by dialing (877)-407-0784
for participants in the U.S. or Canada and (201)-689-8560 for
international callers. A live and archived webcast of the event can
be accessed via the IR Calendar on the News/Events page of the
Investors section of KORU Medical’s website at www.korumedical.com.
The archived webcast will be available for six months.
About KORU Medical Systems
KORU Medical Systems develops, manufactures, and commercializes
innovative and patient-centric large volume subcutaneous infusion
solutions that improve quality of life for patients around the
world. The FREEDOM Syringe Infusion System (the “Freedom System”)
currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion
Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous
Safety Needle Sets™. The Freedom System, which received its first
FDA clearance in 1994, is used for self-administration in the home
by the patient and/or delivery in an ambulatory infusion center by
a healthcare professional. Through its Novel Therapies business,
KORU Medical provides products for use by biopharmaceutical
companies in feasibility/clinical trials during the drug
development process and, as needed, is capable of customizing the
Freedom System for clinical and commercial use across multiple drug
categories. For more information, please visit
www.korumedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240717571985/en/
Investor Contact: Greg Chodaczek 347-620-7010
investor@korumedical.com
KORU Medical Systems (NASDAQ:KRMD)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
KORU Medical Systems (NASDAQ:KRMD)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
